Record NNP B-NP O
date NN I-NP O
: : O O
2083-01-12 CD O B-DATE
CCU NNP B-NP O
Admission NNP I-NP O
Note NN I-NP O
Patient NNP B-NP O
is VBZ B-VP O
transferred VBN I-VP O
from IN B-PP O
Florida NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
Orland CC O I-HOSPITAL
Otto NNP B-NP B-PATIENT
Qazi NNP I-NP I-PATIENT
MR# NNP B-NP O
527-62-21 CD I-NP B-MEDICALRECORD
Date NNP B-NP O
of IN B-PP O
Admission NNP B-NP O
: : O O
January NNP B-NP B-DATE
12 CD I-NP I-DATE
, , I-NP I-DATE
2083 CD O I-DATE
Admitting NNP B-NP O
JAR NNP I-NP O
: : O O
Hunter NNP B-NP B-DOCTOR
Hayden NNP I-NP I-DOCTOR
, , O O
MD . O O
Attending VBG B-VP O
: : O O
Quinten NNP B-NP B-DOCTOR
Prado NNP I-NP I-DOCTOR
, , O O
MD . O O
Reason NN B-NP O
for IN B-PP O
Transfer NNP B-NP O
: : O O
STEMI NNP O O
HPI NNP B-NP O
: : O O
58 CD B-NP B-AGE
yoM NNP I-NP O
with IN B-PP O
h/o NN B-NP O
CAD NN I-NP O
, , O O
HTN NNP B-NP O
, , O O
smoking NN B-NP O
; : O O
presents NNS B-NP O
to TO B-PP O
FHO NNP B-NP B-HOSPITAL
with IN B-PP O
chest NN B-NP O
pain NN I-NP O
and CC O O
found VBD B-VP O
to TO I-VP O
have VB I-VP O
lateral JJ B-NP O
STEMI NNS I-NP O
. . O O
He PRP B-NP O
experienced VBD B-VP O
mild JJ B-NP O
central JJ I-NP O
chest NN I-NP O
pain NN I-NP O
on IN B-PP O
the DT B-NP O
night NN I-NP O
prior RB B-ADVP O
to TO B-PP O
admission NN B-NP O
while IN B-SBAR O
working VBG B-NP O
outdoors NNS I-NP O
, , O O
pain NN B-NP O
resolved VBN B-VP O
after IN B-PP O
about IN B-PP O
an DT B-NP O
hour NN I-NP O
and CC O O
he PRP B-NP O
attributed VBD B-VP O
it PRP B-NP O
to TO B-PP O
GERD. NNP B-NP O
However RB B-ADVP O
, , O O
he PRP B-NP O
awoke VBD B-VP O
at IN B-PP O
5:30 CD B-NP O
AM VBP B-VP O
on IN B-PP O
the DT B-NP O
morning NN I-NP O
of IN B-PP O
presentation NN B-NP O
with IN B-PP O
recurrence NN B-NP O
of IN B-PP O
chest NN B-NP O
pain NN I-NP O
, , O O
6/10 CD B-NP O
severity NN I-NP O
, , O O
lasted VBD B-VP O
for IN B-PP O
about IN B-NP O
15-30 CD I-NP O
minutes NNS I-NP O
and CC O O
then RB B-VP O
resolved VBN I-VP O
with IN B-PP O
Maalox NNP B-NP O
. . I-NP O
Pain NNP I-NP O
recurred VBD B-VP O
about IN B-PP O
9:30 CD B-NP O
, , O O
of IN B-PP O
similar JJ B-NP O
severity NN I-NP O
, , O O
associated VBN B-VP O
with IN B-PP O
dyspnea NN B-NP O
, , O O
diaphoresis NN B-NP O
, , O O
non JJ B-NP O
radiating NN I-NP O
, , O O
non-pleuritic JJ B-NP O
. . B-VP O
He PRP B-NP O
again RB B-ADVP O
took VBD B-VP O
zantac NN B-NP O
and CC O O
Maalox NNP B-NP O
without IN B-PP O
improvement NN B-NP O
. . O O
After IN B-PP O
15 CD B-NP O
minutes NNS I-NP O
he PRP B-NP O
walked VBD B-VP O
to TO B-PP O
the DT B-NP O
local JJ I-NP O
hospital NN I-NP O
ER NNP B-NP O
and CC B-PP O
during IN B-PP O
walk VBP B-VP O
the DT B-NP O
pain NN I-NP O
increased VBD B-VP O
in IN B-PP O
severity NN B-NP O
to TO B-VP O
8/10 VB I-VP O
. . O O
He PRP B-NP O
describes VBZ B-VP O
the DT B-NP O
pain NN I-NP O
as IN B-PP O
similar JJ B-NP O
to TO B-PP O
his PRP$ B-NP O
previous JJ I-NP O
MI NNP I-NP O
. . O O
Upon IN B-SBAR O
arrival NN B-NP O
to TO B-PP O
FHO NNP B-NP B-HOSPITAL
found VBD B-VP O
to TO I-VP O
have VB I-VP O
ST NNP B-NP O
elevations NNS I-NP O
antero-lateral JJ I-NP O
. . O O
Given VBN B-VP O
lopressor NN B-NP O
, , I-NP O
heparin NN I-NP O
, , I-NP O
integrillin NN I-NP O
, , I-NP O
morphine NN I-NP O
, , O O
ASA NNP B-NP O
, , O O
and CC O O
medivac JJ B-ADJP O
to TO B-VP O
WCH VB I-VP B-HOSPITAL
arranged VBN I-VP O
for IN B-PP O
cath NN B-NP O
. . O O
He PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
by IN B-PP O
the DT B-NP O
time NN I-NP O
he PRP B-NP O
was VBD B-VP O
in IN B-PP O
transit NN B-NP O
, , O O
his PRP$ B-NP O
chest NN I-NP O
pain NN I-NP O
had VBD B-VP O
resolved VBN I-VP O
. . O O
He PRP B-NP O
arrived VBD B-VP O
at IN B-PP O
WCH NNP B-NP B-HOSPITAL
, , O O
was VBD B-VP O
taken VBN I-VP O
directly RB B-ADVP O
to TO B-PP O
cath NN B-NP O
lab NN I-NP O
, , O O
found VBD B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
proximal JJ I-NP O
LAD NN I-NP O
lesion NN I-NP O
with IN B-PP O
cypher NN B-NP O
stent NN I-NP O
placed VBD B-VP O
. . O O
He PRP B-NP O
remained VBD B-VP O
chest NN B-NP O
pain NN I-NP O
free JJ B-VP O
following VBG B-PP O
the DT B-NP O
procedure NN I-NP O
and CC O O
was VBD B-VP O
sent VBN I-VP O
to TO B-PP O
the DT B-NP O
CCU NNP I-NP O
in IN B-PP O
stable JJ B-NP O
condition NN I-NP O
. . O O
At IN B-PP O
baseline NN B-NP O
he PRP B-NP O
states VBZ B-VP O
he PRP B-NP O
can MD B-VP O
walk VB I-VP O
a DT B-NP O
couple NN I-NP O
of IN B-PP O
miles NNS B-NP O
without IN B-PP O
rest NN B-NP O
, , O O
he PRP B-NP O
rarely RB B-ADVP O
takes VBZ B-VP O
stairs NNS B-NP O
on IN B-PP O
a DT B-NP O
daily JJ I-NP O
basis NN I-NP O
. . O O
He PRP B-NP O
smokes VBZ B-VP O
profusely RB B-ADVP O
and CC O O
has VBZ B-VP O
little JJ B-NP O
interest NN I-NP O
in IN B-PP O
quitting VBG B-NP O
. . O O
He PRP B-NP O
feels VBZ B-VP O
he PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
occurrence NN I-NP O
of IN B-PP O
chest NN B-NP O
pain NN I-NP O
since IN B-PP O
last JJ B-NP O
one CD I-NP O
. . O O
However RB B-ADVP O
, , O O
he PRP B-NP O
does VBZ B-VP O
report VB I-VP O
that IN B-SBAR O
his PRP$ B-NP O
plavix NN I-NP O
was VBD B-VP O
stopped VBN I-VP O
recently RB B-ADVP O
, , O O
and CC O O
he PRP B-NP O
has VBZ B-VP O
difficulty NN B-NP O
affording VBG B-VP O
all DT B-NP O
his PRP$ I-NP O
medications NNS I-NP O
. . O O
ROS NNP B-NP O
: : O O
Gen NNP B-NP O
: : O O
denies VBZ B-VP O
f/c/ns VBG I-VP O
HEENT NNP B-NP O
: : O O
no DT B-NP O
dysphagia NN I-NP O
, , O O
throat NN B-NP O
pain NN I-NP O
Chest NNP B-NP O
: : O O
no DT B-NP O
cough NN I-NP O
, , O O
dyspnea NN B-NP O
CV NNP B-NP O
: : O O
denies VBZ B-VP O
orthopnea NNP B-NP O
, , O O
pnd NN B-NP O
GI NNP B-NP O
: : O O
no DT B-NP O
hematochezia NN I-NP O
, , O O
melena NN B-NP O
Skin NNP B-NP O
: : O O
no DT B-NP O
rash NN I-NP O
PMHx NNP B-NP O
: : O O
CAD NN B-NP O
: : O O
Cath NNP B-NP O
1/73 CD I-NP B-DATE
: : O O
80 CD B-NP O
% NN I-NP O
prox NN I-NP O
RCA NNP I-NP O
stenosis NN I-NP O
w/ NN I-NP O
thrombus NN I-NP O
, , O O
mod JJ B-NP O
D1 NNP I-NP O
stenosis NN I-NP O
, , O O
clear JJ B-NP O
Lcx NNP I-NP O
. . I-NP O
LV NNP I-NP O
gram NN I-NP O
EF NNP I-NP O
69 CD I-NP O
% NN I-NP O
, , O O
normal JJ B-NP O
motion NN I-NP O
. . O O
Cath NNP B-NP O
9/8 CD I-NP I-DATE
1 CD I-NP I-DATE
: : O O
Critical JJ B-NP O
proximal JJ I-NP O
ramus NN I-NP O
lesion NN I-NP O
. . B-NP O
RCA NN I-NP O
with IN B-PP O
proximal JJ B-NP O
40 CD I-NP O
% NN I-NP O
lesion NN I-NP O
, , O O
patent NN B-NP O
RCA NN I-NP O
stent NN I-NP O
. . O O
Patent NN B-NP O
left VBD B-VP O
main JJ B-ADJP O
, , O O
apical JJ B-NP O
LAD NN I-NP O
with IN B-PP O
99 CD B-NP O
% NN I-NP O
lesion NN I-NP O
with IN B-PP O
L-L JJ B-NP O
collaterals NNS I-NP O
. . O O
Cfx NN O O
35 CD B-NP O
% NN I-NP O
mid JJ I-NP O
lesion NN I-NP O
. . O O
Normal JJ B-NP O
LVEDP NNP I-NP O
, , O O
no DT B-NP O
AS. NNP I-NP O
LVf NNP I-NP O
50-55 CD I-NP O
% NN I-NP O
. . O O
Also RB B-ADVP O
with IN B-PP O
h/o NN B-NP O
RCA NNP I-NP O
stent NN I-NP O
, , O O
unclear JJ B-NP O
where WRB B-ADVP O
procedure NN B-NP O
was VBD B-VP O
done VBN I-VP O
and CC O O
patient JJ B-NP O
unable JJ I-NP O
to TO B-VP O
recall VB I-VP O
details NNS B-NP O
. . O O
HTN . O O
Hyperlipidemia NNP B-NP O
Medications NNS B-NP O
on IN B-PP O
Admission NNP B-NP O
: : O O
Toprol NNP B-NP O
XL NNP I-NP O
75mg CD I-NP O
daily JJ O O
ASA NNP B-NP O
81mg CD I-NP O
daily JJ O O
Plavix NNP B-NP O
75mg CD I-NP O
daily JJ O O
Lipitor NNP B-NP O
(unknown JJ I-NP O
dose NN I-NP O
) -RRB- O O
MVI . O O
Allergies NNP B-NP O
: : O O
NKDA NNP B-NP O
SH NNS B-NP O
: : O O
Works NNP B-NP O
as IN B-PP O
an DT B-NP O
IS VBZ B-VP B-PROFESSION
consultant NN B-NP I-PROFESSION
in IN B-PP O
East NNP B-NP B-CITY
Liverpool NNP I-NP I-CITY
. . O O
Also RB O O
a DT B-NP O
counsellor NN I-NP B-PROFESSION
. . O O
He PRP B-NP O
has VBZ B-VP O
h/o VBN I-VP O
drug/ETOH RB B-NP O
abuse NN I-NP O
but CC O O
denies VBZ B-VP O
x NNP B-NP O
25 CD I-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
not RB I-VP O
married VBN I-VP O
, , O O
no DT B-NP O
children NNS I-NP O
. . O O
Tobacco NNP B-NP O
: : O O
+ NN B-NP O
for IN B-PP O
40 CD B-NP O
years NNS I-NP O
2-4ppd JJ B-ADJP O
. . O O
FH NNP B-NP O
: : O O
Mother NN B-NP O
: : O O
deceased VBN B-VP O
in IN B-PP O
60 CD B-NP B-AGE
s VBZ B-VP I-AGE
with IN B-PP O
leukemia NN B-NP O
Father NNP B-NP O
: : O O
extensive JJ B-NP O
CAD NN I-NP O
, , O O
with IN B-PP O
first JJ B-NP O
MI NNP I-NP O
in IN B-PP O
50 CD B-NP B-AGE
s VBZ I-NP I-AGE
. . O O
Had VBD B-VP O
MI NNP B-NP O
x7 CD I-NP O
, , O O
died VBD B-VP O
in IN B-PP O
70s CD B-NP B-AGE
. . O O
Exam NNP B-NP O
: : O O
VS NNP B-NP O
: : O O
T NNP B-NP O
97.2 CD I-NP O
HR NNP I-NP O
57 CD I-NP O
BP NNP I-NP O
102/62 CD I-NP O
RR NNP B-NP O
18 CD I-NP O
O2 CD I-NP O
96 CD I-NP O
% NN I-NP O
General NNP B-NP O
: : O O
obese NN B-NP O
, , O O
non-toxic JJ B-NP O
appearing VBG I-NP O
WM NNP I-NP O
, , O O
NAD NNP B-NP O
HEENT NNP B-NP O
: : O O
NC/AT NN B-NP O
, , O O
MM NNP B-NP O
dry JJ I-NP O
, , O O
OP NNP B-NP O
clear JJ I-NP O
without IN B-PP O
lesion NN B-NP O
to TO B-PP O
oral JJ B-NP O
mucosa NN I-NP O
Skin NNP B-NP O
: : O O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
rash NN B-NP O
, , O O
wound NN B-NP O
. . O O
Neck NNP B-NP O
: : O O
Supple NN B-NP O
, , O O
full JJ B-NP O
ROM NNP I-NP O
, , O O
2+ CD B-NP O
carotids NNS I-NP O
w/o IN B-PP O
bruits NNS B-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
or CC I-NP O
nodules NNS I-NP O
, , O O
no DT B-NP O
nodes NNS I-NP O
Chest NNP B-NP O
: : O O
CTA NNP B-NP O
B NNP I-NP O
, , O O
no DT B-NP O
crackles NNS I-NP O
, , O O
rhonchi NNP B-NP O
, , O O
wheeze NN B-NP O
. . O O
CVS NNP B-NP O
: : O O
PMI NNP B-NP O
nondisplaced VBD B-VP O
, , O O
RRR NNP B-NP O
nl , O O
S1 NNP B-NP O
S2 NNP I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
Abd NNP B-NP O
: : O O
Soft/nontender/non-distended JJ O O
Extr NNP B-NP O
: : O O
no DT B-NP O
c/c/e NN I-NP O
2+ IN B-PP O
DP NNP B-NP O
's POS B-NP O
bilaterally NN I-NP O
, , O O
no DT B-NP O
hematoma NN I-NP O
or CC I-NP O
bruit NN I-NP O
femoral JJ I-NP O
B. NNP I-NP O
Oozing NNP I-NP O
from IN B-PP O
R NN B-NP O
femoral JJ I-NP O
stick NN I-NP O
. . O O
Neuro NNP B-NP O
: : O O
AAOX3 NNP B-NP O
, , O O
MS NNP B-NP O
nl NN I-NP O
, , O O
non-focal/non-lateralizing JJ B-ADJP O
. . O O
DATA NNP B-NP O
: : O O
NA NNP B-NP O
133( JJ I-NP O
L NNP I-NP O
) -RRB- O O
K NNP B-NP O
3.9 CD I-NP O
CL NN B-NP O
107 CD I-NP O
CO2 NN B-NP O
22.4( JJ I-NP O
L NNP I-NP O
) -RRB- O O
BUN NNP B-NP O
11 CD I-NP O
CRE NNP B-NP O
0.9 CD I-NP O
GLU NNP B-NP O
230( CD I-NP O
H) . O O
CK-MB NNP B-NP O
11.3( CD I-NP O
H) . O O
TROP-T NNP B-NP O
0.18( CD I-NP O
H) . O O
WBC NNP B-NP O
9.7 CD I-NP O
RBC NNP B-NP O
4.14( JJ I-NP O
L NNP I-NP O
) -RRB- O O
HGB NNP B-NP O
13.5 CD I-NP O
HCT NNP B-NP O
36.6( JJ I-NP O
L NNP I-NP O
) -RRB- O O
MCV NNP B-NP O
88 CD I-NP O
MCH NNP B-NP O
32.7 CD I-NP O
MCHC NNP B-NP O
37.0 CD I-NP O
PLT NNP B-NP O
159 CD I-NP O
RDW NNP B-NP O
13.1 CD I-NP O
CXR NN B-NP O
: : O O
EKG NNP B-NP O
: : O O
FHO NNP B-NP B-HOSPITAL
presentation NN I-NP O
: : O O
Sinus NNP B-NP O
at IN B-PP O
80bpm JJ B-ADJP O
, , O O
Left VBN B-NP O
axis NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
1-2mm JJ B-NP O
ST NNP I-NP O
elevations/hyperacute NN I-NP O
TW NNP I-NP O
V2-V3 NNP I-NP O
, , O O
1mm UH B-NP O
STelevation NNP I-NP O
I/aVL NNP I-NP O
, , O O
1mm UH B-NP O
ST NNP I-NP O
depression/TW NN I-NP O
I PRP B-NP O
II/III/aVF. MD O O
Admission NNP B-ADJP O
to TO B-VP O
CCU NNP B-NP O
s/p NN I-NP O
cath NN I-NP O
: : O O
Resolution NNP B-NP O
of IN B-PP O
ST NNP B-NP O
elevations NNS I-NP O
I/aVL NNP I-NP O
, , O O
persistent JJ B-NP O
TWI NNP I-NP O
aVL NN I-NP O
, , O O
Qwaves NNP B-NP O
V2-V3 NNP I-NP O
, , O O
1mm IN B-PP O
STE NNP B-NP O
V2-V3 NNP I-NP O
, , O O
TW NNP B-NP O
height NN I-NP O
has VBZ B-VP O
improved VBN I-VP O
; : O O
ST NNP B-NP O
depressions NNS I-NP O
inferior JJ I-NP O
leads NNS I-NP O
have VBP B-VP O
resolved VBN I-VP O
. . O O
CXR:No DT B-NP O
focal JJ I-NP O
opacity NN I-NP O
or CC I-NP O
airspace NN I-NP O
disease NN I-NP O
. . O O
No DT B-NP O
evidence NN I-NP O
of IN B-PP O
CHF. NNP B-NP O
Impression NN B-NP O
: : O O
58 CD B-NP B-AGE
yoM NNP I-NP O
with IN B-PP O
risk NN B-NP O
factors NNS I-NP O
including VBG B-PP O
CAD NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
HL NNP B-NP O
, , O O
presents VBZ B-VP O
with IN B-PP O
evidence NN B-NP O
of IN B-PP O
antero-lateral JJ B-NP O
infarction NN I-NP O
by IN B-PP O
EKG NNP B-NP O
and CC O O
history NN B-NP O
transferred VBN B-VP O
from IN B-PP O
OSH NNP B-NP O
for IN B-PP O
cath NN B-NP O
and CC O O
PCI. NNP B-NP O
He PRP B-NP O
is VBZ B-VP O
stable JJ B-NP O
post-cath NN I-NP O
, , O O
with IN B-PP O
resolving VBG B-VP O
EKG JJ B-NP O
changes NNS I-NP O
; : O O
had VBD B-VP O
cypher JJ B-NP O
stent NN I-NP O
to TO B-PP O
proximal JJ B-NP O
LAD NN I-NP O
felt VBD B-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
culprit NN I-NP O
lesion NN I-NP O
due JJ B-ADJP O
to TO B-PP O
the DT B-NP O
EKG JJ I-NP O
changes NNS I-NP O
. . O O
He PRP B-NP O
continues VBZ B-VP O
to TO I-VP O
be VB I-VP O
chest NN B-NP O
pain NN I-NP O
free JJ I-NP O
post-cath NN I-NP O
. . O O
Plan NNP B-NP O
: : O O
Ischemia NNP B-NP O
: : O O
BB NNP B-NP O
, , O O
ASA NNP B-NP O
325mg CD I-NP O
, , I-NP O
plavix NN I-NP O
, , I-NP O
lipitor NN I-NP O
80mg JJ I-NP O
daily RB B-ADVP O
. . O O
Continue NNP B-NP O
integrillin NN I-NP O
for IN B-PP O
12 CD B-NP O
hours NNS I-NP O
Follow VB B-NP O
markers NNS I-NP O
, , O O
daily RB B-ADVP O
EKG . O O
Lipids NNS B-NP O
, , O O
HbA1c . O O
Cardiac NNP B-NP O
rehab NN I-NP O
, , O O
smoking VBG B-VP O
cessation NN B-NP O
consult VB B-VP O
, , O O
nutrition NN B-NP O
counseling NN I-NP O
Rhythm NN B-NP O
: : O O
Currently RB B-ADVP O
sinus IN B-PP O
rhythm NN B-NP O
lopressor NN B-NP O
Monitoring NN B-NP O
in IN B-PP O
CCU NNP B-NP O
for IN B-PP O
arrhythmia NN B-NP O
Pump NNP B-NP O
: : O O
No DT B-NP O
h/o NN I-NP O
CHF NN I-NP O
Given VBN B-NP O
anterior JJ I-NP O
infarct NN I-NP O
, , O O
will MD B-VP O
obtain VB I-VP O
TTE NN B-NP O
Prophy NNP B-NP O
: : O O
Nexium NNP B-NP O
, , O O
when WRB B-ADVP O
off RP B-NP O
integrillin NNS I-NP O
consider VBP I-NP O
add VB I-NP O
lovenox NN I-NP O
prophylactically RB O O
Dispo NNP B-NP O
: : O O
To TO B-NP O
SDU NNP B-NP O
when WRB B-ADVP O
stable JJ B-NP O
x NN I-NP O
24h JJ I-NP O
and CC I-NP O
markers NNS I-NP O
peak NN I-NP O
. . O O
L. NNP B-NP B-DOCTOR
Hunter NNP I-NP I-DOCTOR
Hayden NNP I-NP I-DOCTOR
, , O O
MD . O O
Pager NNP B-NP O
# # I-NP O
50173 CD O B-PHONE
